Implantable medical devices with active component monitoring

• US 10,159,847 B2
• Filed: 05/20/2015
• Issued: 12/25/2018
• Est. Priority Date: 05/20/2015
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Rasmussen, Marshall J., Cabelka, Lonny V., Crutchfield, Randolph E., Zimmer, Jon E.
• Primary Examiner(s): Bockelman, Mark W
• Application Number:
  US14/717,773
• Publication Number:
  US 20160339260A1
• Time in Patent Office: 1,315 Days
• CPC Class Codes: A61N 1/36142 for improving safety
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/3937 Monitoring output parameters
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

An implantable medical device includes a housing, a power source and an operational circuit that is coupled to the power source. The operational circuit includes a first electrode terminal and a second electrode terminal, an output circuit configured to deliver an electrical stimulation therapy through the first and second electrode terminals and a control circuit configured to evaluate an electrical parameter associated with the output circuit and to control generation of the electrical stimulation therapy responsive to a result of the evaluated parameter. Among other things, the implantable medical device may modify a parameter of the therapy delivery in response to a result of the evaluation.

Claims

1. An implantable medical system, comprising:

a housing;

a power source disposed within the housing; and

an operational circuit disposed within the housing and coupled to the power source, the operational circuit comprising;

a first electrode terminal and a second electrode terminal,

an output circuit configured to deliver an electrical stimulation therapy through the first and second electrode terminals, wherein the output circuit includes at least four interconnected switches arrayed having a high side and a low side, wherein each of the at least four interconnected switches is configurable to be biased between a non-conducting state and a conducting state, and wherein at least two of the at least four interconnected switches is biased to a conducting state when electrical stimulation therapy is delivered through the first and second electrode terminals,

one or more capacitors coupled to and configured to be charged using the power source and coupled to the output circuit, the one or more capacitors being configured to store energy for discharge and delivery of the electrical stimulation therapy through the output circuit, and

a control circuit configured to;

issue a charge command to initiate charging of the one or more capacitors with each of the at least four interconnected switches in a non-conducting state, wherein each of the at least four interconnected switches in the non-conducting state has a leakage current flowing through the switch,

measure and evaluate an electrical parameter associated with the output circuit, wherein the control circuit biases the at least four interconnected switches into the non-conducting state during the measurement of the electrical parameter, wherein the measured electrical parameter is based on a leakage current flowing through at least one of the at least four interconnected switches biased in the non-conducting state and measured across a load comprising the heart, and

once the one or more capacitors are charged to a selected energy, issue a control signal to trigger discharge and delivery of the electrical stimulation therapy through the output circuit by biasing two or more of the switches into a conducting state, wherein the generation of electrical stimulation therapy is controlled responsive to a result of the evaluated parameter.

2. The implantable medical system of claim 1, the high side having a first switch and a third switch and the low side having a second switch and a fourth switch, wherein the first electrode terminal is coupled between the first and second switches and the second electrode terminal is coupled between the third and fourth switches, and further wherein each of the four interconnected switches comprises a solid-state semiconductor device.

3. The implantable medical system of claim 2, wherein the first and third switches comprise anode gated thyristors (AGT) and the second and fourth switches comprise insulated gate bipolar transistors (IGBT).

4. The implantable medical system of claim 1, further comprising a monitoring circuit coupled to the control circuit, the monitoring circuit being configured to measure the electrical parameter of the output circuit, wherein the monitoring circuit includes a voltage comparator configured to evaluate the electrical parameter of at least one component of the output circuit.

5. The implantable medical system of claim 1, further comprising a lead coupled to the housing, the lead including at least a first electrode coupled to the first electrode terminal.

6. The implantable medical system of claim 1, further comprising:

at least a third electrode terminal, and

a lead coupled to the housing, the lead including at least a first electrode and a second electrode coupled to the first and second electrode terminals respectively.

7. The implantable medical system of claim 1, further comprising a second electrode coupled to the housing, the second electrode being coupled to the second electrode terminal.

8. The implantable medical system of claim 1, wherein the high side is coupled to a terminal of the one or more capacitors without any additional switch coupled between the high side and the one or more capacitors.

9. An implantable medical system, comprising:

a housing;

a power source disposed within the housing; and

an operational circuit disposed within the housing and coupled to the power source, the operational circuit comprising;

a first electrode terminal and a second electrode terminal,

an output circuit configured to deliver an electrical stimulation therapy through the first and second electrode terminals, wherein the output circuit includes at least four interconnected switches arrayed having a high side and a low side, wherein each of the at least four interconnected switches is configurable to be biased between a non-conducting state and a conducting state, and wherein at least two of the at least four interconnected switches is biased to a conducting state when electrical stimulation therapy is delivered through the first and second electrode terminals,

one or more capacitors coupled to and configured to be charged using the power source and coupled to the output circuit, the one or more capacitors being configured to store energy for discharge and delivery of the electrical stimulation therapy through the output circuit, wherein the high side of the output circuit is coupled to a terminal of the one or more capacitors without any additional switch coupled between the high side and the one or more capacitors, and

a control circuit operably coupled to the first electrode terminal and the second electrode terminal to measure and evaluate an electrical parameter associated with the output circuit, the control circuit configured to;

issue a charge command to initiate charging of the one or more capacitors with each of the at least four interconnected switches in a non-conducting state, wherein each of the at least four interconnected switches in the non-conducting state has a leakage current flowing through the switch,

measure and evaluate the electrical parameter from the first electrode terminal and the second electrode terminal, wherein the control circuit biases the at least four interconnected switches into the non-conducting state during the measurement of the electrical parameter, wherein the measured electrical parameter is based on a leakage current flowing through at least one of the at least four interconnected switches biased in the non-conducting state, and

once the one or more capacitors are charged to a selected energy, issue a control signal to trigger discharge and delivery of the electrical stimulation therapy through the output circuit by biasing two or more of the switches into a conducting state, wherein the generation of electrical stimulation therapy is controlled responsive to a result of the evaluated parameter.

10. The implantable medical system of claim 9, wherein the high side having a first switch and a third switch and the low side having a second switch and a fourth switch, wherein the first electrode terminal is coupled between the first and second switches and the second electrode terminal is coupled between the third and fourth switches.

11. The implantable medical system of claim 10, wherein each of the four interconnected switches comprises a solid-state semiconductor device.

12. The implantable medical system of claim 10, wherein the first and third switches comprise anode gated thyristors (AGT) and the second and fourth switches comprise insulated gate bipolar transistors (IGBT).

13. The implantable medical system of claim 9, wherein the electrical parameter is selected from one of a voltage and a current.

14. The implantable medical system of claim 9, further comprising a monitoring circuit coupled to the control circuit, the monitoring circuit being configured to measure the electrical parameter of the output circuit, wherein the monitoring circuit includes a voltage comparator configured to evaluate the electrical parameter of at least one component of the output circuit.

15. The implantable medical system of claim 9, further comprising a lead coupled to the housing, the lead including at least a first electrode coupled to the first electrode terminal.

16. The implantable medical system of claim 9, further comprising:

at least a third electrode terminal, and

a lead coupled to the housing, the lead including at least a first electrode and a second electrode coupled to the first and second electrode terminals respectively.

17. The implantable medical system of claim 9, further comprising a second electrode coupled to the housing, the second electrode being coupled to the second electrode terminal.